Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)

计划入组 66 人 · 首次发布于 2016 年 7 月 13 日

RSV-F Vaccine Dose Ranging Study in Young Women

计划入组 330 人 · 首次发布于 2012 年 10 月 11 日

RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly

计划入组 220 人 · 首次发布于 2012 年 10 月 17 日

RSV F protein vaccine (Novavax)

RSV-F protein subunit vaccine (GlaxoSmithKline)

Gontivimab

Protein Sciences Corporation

United States

RSV Therapeutics LLC

Casper, Dr Robert F

Canada

China approves two homegrown long-acting RSV antibodies for infants, challenging Beyfortus

RSV Therapeutic Pipeline Shows Promise with Novel Therapies and Clinical Advancements

Safety and Efficacy of AK0529 in Respiratory Syncytial Virus-Infected Infant Patients